Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.5K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Changing Face of Gastrointestinal Cancer Mortality: Trends and Divide by Age and Geography.

Annals of surgical oncology·2026
Same author

Subjective Cognitive Decline in US Cancer Survivors: Sociodemographic, Behavioral, and Clinical Determinants.

JCO oncology practice·2026
Same author

Does Cannabinoid Use Reduce Opioid Utilization Among Patients with Gastrointestinal Cancer? Evidence from Epic COSMOS.

Cancers·2026
Same author

Five Advances in the Last 50 Years: Liver Malignancies.

World journal of surgery·2026
Same author

Impact of Cancer on Pregnancy and Fertility Service Use in Reproductive-Aged Women.

Journal of primary care & community health·2026
Same author

ASO Visual Abstract: Occult Nodal Disease in Gallbladder Cancer: An International Multi-institutional Analysis and Preoperative Risk Stratification.

Annals of surgical oncology·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Nov 9, 2025

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
05:59

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Published on: August 30, 2019

12.0K

Liver metastases.

Diamantis I Tsilimigras1, Pnina Brodt2, Pierre-Alain Clavien3

  • 1Department of Surgery, The Ohio State University, Wexner Medical Center, Columbus, OH, USA.

Nature Reviews. Disease Primers
|April 16, 2021
PubMed
Summary
This summary is machine-generated.

Liver metastases, common in cancers like colorectal cancer, involve complex tumor microenvironment interactions. Advanced treatments and genetic testing offer improved management and prognosis for liver metastases.

More Related Videos

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

42.0K
A Preclinical Murine Model of Hepatic Metastases
06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

29.6K

Related Experiment Videos

Last Updated: Nov 9, 2025

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
05:59

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Published on: August 30, 2019

12.0K
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

42.0K
A Preclinical Murine Model of Hepatic Metastases
06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

29.6K

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Liver metastases are frequent in various cancers, notably colorectal cancer (CRC).
  • Tumor microenvironment interactions are crucial for metastasis engraftment, survival, and progression.
  • Key cellular players include liver sinusoidal endothelial cells, Kupffer cells, and immune cells.

Purpose of the Study:

  • To review the pathophysiology, diagnosis, and treatment of liver metastases.
  • To highlight the role of the tumor microenvironment in liver metastasis.
  • To discuss current and emerging therapeutic strategies.

Main Methods:

  • Literature review of liver metastasis pathophysiology, diagnosis, and treatment.
  • Analysis of the cellular and molecular interactions within the liver microenvironment.
  • Evaluation of diagnostic imaging modalities and therapeutic approaches.

Main Results:

  • Liver metastasis involves distinct phases: microvascular, pre-angiogenic, angiogenic, and growth.
  • Diagnosis commonly utilizes ultrasonography, CT, MRI, and PET scans.
  • Treatment options range from surgical resection to systemic therapies, biologics, and immunotherapy.

Conclusions:

  • Liver metastasis is a complex process influenced by the tumor microenvironment.
  • Surgical resection is potentially curative for resectable cases, while other treatments are evolving.
  • Genetic testing holds promise for personalized treatment decisions and prognosis prediction.